Little Action Post-Earnings For Nu Skin

Shares of Nu Skin Enterprises, Inc. NUS traded slightly down in Thursday’s after-hours session, following the announcement of the company’s Q2 results. EPS of $0.79 were in line with the Street’s consensus, while revenue of $600.475 million beat estimates of $581 million to $583 million.

For the ongoing quarter, management said it expects EPS between $0.80 and $0.84, above analysts’ consensus of $0.77. For the full year, the team guided for EPS of $2.80 to $2.90, versus estimates of $2.79.

"We are pleased with our second-quarter results and remain optimistic about the future as we continue to introduce our latest ageLOC products," said President and CEO Truman Hunt. "During the quarter, we held significant product introduction events in South Asia/Pacific and Greater China, generating revenue growth of 36 and 18 percent, respectively. We are also encouraged with the increase in sales leaders during the quarter, a reflection of the strength of our product launches."

Management announced a quarterly dividend of $0.355 per share, payable on September 14, to stockholders of record by August 26, and the addition of a new member to the company’s Board of Directors.

Simon Shen, a representative of the Ping An ZQ China Growth Limited investment group will provide “valuable expertise” in helping Nu Skin realize its growth potential in China, Steven J. Lund, executive chairman of the board, commented.